Hyperplastic perilobar nephroblastomatosis: Long‐term survival of 52 patients
Citations Over TimeTop 23% of 2005 papers
Abstract
Abstract Background This study provides insight into the clinical behavior, diagnostic complexities, and long‐term management of patients with hyperplastic perilobar nephroblastomatosis (HPLN). Procedure Fifty‐two patients with HPLN with available long‐term follow‐up were retrospectively analyzed for pathologic, radiologic, and clinical features. Results The mean age at diagnosis was 16 months; the lesions were bilateral in 49 patients. Of 33 patients who initially underwent diagnostic biopsy and adjuvant chemotherapy, 18 (55%) developed Wilms tumor (WT) at a mean of 35 months from diagnosis. Of 16 patients whose initial therapy included nephrectomy and adjuvant therapy, three (19%) developed WT at a mean of 36 months from diagnosis. All three patients who underwent initial diagnostic biopsy and received no adjuvant therapy during their initial course developed WT 4, 4, and 10 months following diagnosis. 24/52 patients developed either a single (13 patients) or multiple (11 patients) WT throughout their course; 8/24 (33%) of WT were anaplastic. The time from initial diagnosis to the development of the last WT ranged from 13 to 116 months (mean 42 months). Three children with HPLN died of WT at 3, 5, and 6 years of age; 2/3 were anaplastic. Conclusions HPLN is a self‐limited, pre‐neoplastic proliferative process associated with a high risk of developing WT. The accurate diagnosis and the choices of therapy during the often‐complex course of HPLN depend on the availability and accurate interpretation of a combination of pathologic, radiologic, and clinical information. When such information is appropriately obtained, the long‐term survival of patients with HPLN is excellent. © 2005 Wiley‐Liss, Inc.
Related Papers
- → National Trends in the Use of Partial Nephrectomy: A Rising Tide That Has Not Lifted All Boats(2012)118 cited
- → Midterm results of radiofrequency ablation versus nephrectomy for T1a renal cell carcinoma(2010)93 cited
- → Relationship between surgical volume and outcomes in nephron-sparing surgery(2014)15 cited
- → Partial Nephrectomy in the Treatment of Localized Renal Cell Carcinoma — Experience of Taichung Veterans General Hospital(2007)5 cited
- → Robot Assisted Partial Nephrectomy: Technique and Outcomes(2019)4 cited